orf
also
known
contagi
ecthyma
cutan
pustular
dermat
acut
contagi
diseas
sheep
goat
wild
rumin
human
worldwid
caus
orf
viru
orfv
epitheliotrop
parapoxviru
prototyp
member
genu
parapoxviru
famili
poxvirida
orfv
gener
induc
prolif
selflimit
lesion
around
mouth
teat
skin
affect
anim
especi
young
lamb
mortal
rate
high
kid
lesion
lip
udder
prevent
receiv
nutrit
thu
lead
rapid
emaci
outbreak
orf
occur
mani
countri
substanti
number
sheep
goat
rais
diseas
caus
huge
econom
loss
sheep
industri
also
zoonot
diseas
pose
threat
human
health
orfv
genom
approxim
doublestrand
dna
contain
least
put
gene
like
poxvirus
orfv
genom
contain
larg
central
code
region
orf
includ
homologu
conserv
poxviru
gene
involv
basic
replic
mechan
structur
morphogenesi
intracellular
matur
extracellular
envelop
virion
bound
two
ident
invert
termin
repeat
region
encod
dna
polymeras
dna
pol
core
enzym
process
orfv
replic
catalyz
replic
viral
genom
rna
interfer
rnai
conserv
genesilenc
mechan
induc
nt
small
interf
rna
sirna
molecul
homolog
target
gene
rnai
technolog
power
tool
function
genom
studi
also
potenti
use
antivir
method
increasingli
use
inhibit
replic
viral
pathogen
therefor
suggest
prefer
method
control
viru
interfer
replic
viral
genom
express
viral
gene
design
specif
sirna
target
dna
polymeras
gene
orfv
order
test
whether
rnai
could
select
target
orfv
viral
dna
studi
provid
experiment
basi
develop
new
antiorfv
strategi
also
new
approach
studi
orfv
infect
replic
primari
ovin
fetal
turbin
oftu
cell
cultur
minim
essenti
medium
mem
hyclon
fetal
bovin
serum
fb
hyclon
mm
lglutamin
u
penicillin
streptomycin
nystatin
per
ml
incub
orf
viru
isol
scab
collect
lesion
smalltail
han
sheep
show
typic
symptom
orf
viru
infect
novemb
jilin
provinc
china
virusinfect
cell
show
cytopath
effect
cpe
cultur
collect
undergo
three
freezethaw
cycl
dna
extract
cpeposit
cell
cultur
use
takara
minibest
viral
dna
extract
kit
takara
dalian
china
accord
manufactur
instruct
use
templat
pcr
gene
amplifi
pcr
dna
extract
cpeposit
cell
cultur
complet
dna
polymeras
gene
sequenc
divid
three
section
call
dna
polymeras
dna
polymeras
ii
dna
polymeras
iii
specif
primer
design
use
primer
premier
softwar
base
publish
orfv
strain
genom
sequenc
avail
ncbi
genbank
databas
access
number
primer
custom
synthes
shanghai
sangon
biolog
engin
technolog
servic
co
ltd
china
six
primer
set
use
studi
specif
tabl
pcr
dna
polymeras
initi
denatur
step
min
follow
cycl
final
extens
min
pcr
dna
polymeras
ii
initi
denatur
step
min
follow
cycl
min
final
extens
min
pcr
dna
polymeras
iii
initi
denatur
step
min
follow
cycl
final
extens
min
pcr
carri
reaction
mixtur
contain
pcr
buffer
mm
dntp
mm
oligonucleotid
primer
ng
dna
sampl
u
rtaq
dna
polymeras
takara
dalian
china
steril
water
amplicon
visual
electrophoresi
agaros
gel
document
use
gel
document
system
pcr
product
dna
polymeras
ii
iii
fragment
clone
vector
takara
dalian
china
use
transform
e
coli
least
six
posit
clone
select
amplif
product
sequenc
shanghai
sangon
biolog
engin
technolog
servic
co
ltd
china
three
sequenc
combin
obtain
complet
sequenc
base
complet
sequenc
four
pair
sirna
neg
sirna
control
scrambl
sirna
design
synthes
shanghai
genepharma
co
ltd
sequenc
shown
tabl
oftu
cell
cultur
plate
concentr
cellswel
incub
incub
atmospher
cell
confluent
sirna
introduc
use
xtremegen
sirna
transfect
reagent
roch
usa
accord
manufactur
protocol
briefli
transfect
reagent
sirna
ad
well
incub
h
cell
wash
mem
without
serum
cultur
h
mem
supplement
fetal
bovin
serum
prior
viral
infect
sirnatr
cell
infect
orfv
infect
allow
proceed
indic
time
period
untransfect
oftu
cell
use
control
infect
oftu
cell
cultur
supernat
collect
h
orfv
infect
dna
extract
collect
cpeposit
cell
cultur
use
takara
minibest
viral
dna
extract
kit
takara
dalian
china
accord
manufactur
instruct
pcr
use
amplifi
gene
genbank
access
fp
rp
primer
design
use
primer
premier
softwar
condit
min
follow
cycl
final
extens
min
pcr
product
gelpurifi
use
agaros
gel
dna
extract
kit
roch
clone
vector
promega
corp
madison
wisc
usa
result
plasmid
correct
sequenc
confirm
direct
sequenc
select
quantit
standard
determin
viral
dna
copi
number
realtim
pcr
perform
use
pcr
cycler
bio
easi
sybr
realtim
pcr
kit
hangzhou
bioer
technolog
co
ltd
china
condit
min
follow
cycl
final
extens
min
standard
curv
determin
orfv
genom
copi
number
creat
realtim
pcr
standard
plasmid
prepar
serial
dilut
specif
realtim
pcr
confirm
sequenc
product
specif
product
expect
size
bp
bp
bp
fig
obtain
sampl
extract
cpeposit
oftu
cell
amplifi
pcr
nucleotid
sequenc
amplicon
combin
obtain
complet
sequenc
orfv
gene
bp
transfect
complex
sirna
transfect
reagent
complet
remov
transfect
h
orf
viru
suspens
ad
well
untransfect
cell
use
control
h
orf
viru
infect
observ
cpe
indic
appear
inhibit
viru
replic
vari
degre
fig
investig
inhibitori
effect
sirna
microtit
method
use
titrat
orf
viru
postinfect
result
fig
show
control
cell
transfect
scrambl
sirna
titer
reach
ml
h
postinfect
similar
mock
transfect
contrast
titer
h
postinfect
ml
cell
transfect
respect
correspond
reduct
comparison
cell
transfect
scrambl
sirna
quantifi
effect
sirna
viral
replic
viral
genom
copi
number
determin
h
postinfect
realtim
quantit
pcr
use
serial
dilut
plasmid
standard
correl
coeffici
standard
curv
pcr
amplif
effici
e
one
peak
dissoci
curv
therebi
demonstr
specif
reliabl
analysi
result
indic
signific
reduct
rel
express
level
viral
genom
per
nanogram
total
dna
respect
compar
mock
group
h
postinfect
respect
use
fig
rnai
rnamedi
pathway
gene
silenc
mediat
small
rna
molecul
introduct
doublestrand
rna
dsrna
encod
subsequ
gene
lead
reduct
express
correspond
gene
variou
organ
includ
anim
plant
long
doublestrand
rna
cleav
endonucleas
dicer
fragment
small
interf
rna
sirna
oligonucleotid
serv
guid
sequenc
direct
multicompon
nucleas
specif
messeng
rna
destroy
studi
antivir
activ
sirna
shown
effect
inhibit
viral
infect
modul
viral
replic
cultur
mammalian
cell
exampl
includ
sever
acut
respiratori
syndrom
viru
hepat
c
viru
influenza
viru
swine
fever
viru
porntrakulpipat
et
al
goatpox
viru
newcastl
diseas
viru
rnai
increasingli
use
inhibit
replic
viral
pathogen
promis
approach
antivir
therapi
mammal
sirna
introduc
mammalian
cell
vitro
transcript
transfect
chemic
synthes
sirna
achiev
effect
rapid
silenc
target
gene
although
approach
limit
cell
transfect
high
rate
effect
transient
dna
polymeras
gene
locat
central
region
genom
orfv
highli
conserv
within
speci
highli
conserv
gene
code
conserv
nonstructur
protein
catalyz
replic
viral
genom
play
primari
role
viral
replic
present
studi
complet
genom
sequenc
orfv
jilin
isol
determin
three
pair
sirna
synthes
base
complet
open
read
frame
dna
polymeras
gene
orfv
jilin
isol
sirna
import
cell
vitro
transfect
effici
inhibit
viral
replic
test
use
three
assay
cpe
determin
realtim
pcr
result
demonstr
three
sirna
highli
capabl
inhibit
viral
dna
genom
replic
base
replic
kinet
orfv
oftu
cell
prior
sirna
transfect
peak
period
viral
prolifer
data
shown
cell
cultur
viral
titrat
dna
extract
harvest
h
postinfect
h
viru
infect
differ
cpe
indic
inhibit
viru
replic
vari
degre
fig
examin
level
viral
inhibit
test
viral
titer
infect
cell
assay
result
show
sirna
caus
approxim
decreas
viru
yield
furthermor
result
realtim
pcr
indic
approxim
less
viral
dna
present
cell
transfect
sirna
control
cell
summari
use
rnai
direct
orfv
dna
polymeras
gene
could
effect
inhibit
viral
replic
base
present
data
advantag
sirna
technolog
propos
sirna
target
dna
polymeras
gene
may
use
tool
studi
orfv
replic
pathogenesi
futur
studi
